Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Mk.33 Regulatory News (83NF)

Share Price Information for Natwest Mk.33 (83NF)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
83NF Live PriceLast checked at - London Stock Exchange

Intraday Natwest Mk.33 Share Chart

Publication of Final Terms

22 Mar 2023 17:38

RNS Number : 9222T
Natwest Markets PLC
22 March 2023
 

NatWest Markets Plc

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 21 March 2023 (the "Final Terms") for NatWest Markets Plc ("NatWest Markets") for the JPY 10,000,000,000 Senior Fixed Rate Notes due 23 March 2028 (ISIN: XS2601930238) (the "Notes") issued under the £15,000,000,000 Euro Medium Term Note Programme of NatWest Markets (the "Programme"). 

The Final Terms contain the final terms of the Notes and must be read in conjunction with the prospectus dated 7 December 2022 and the supplemental prospectus dated 17 February 2023, relating to the Programme (together, the "Prospectus"), which constitute a base prospectus for the purposes of the Prospectus Regulation (EU) 2017/1129 as it forms part of domestic law in the UK by virtue of the European Union (Withdrawal) Act 2018.

To view the Final Terms, please paste the following URLs into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9222T_1-2023-3-22.pdf

A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Mark Anwender

Head of Documentation and Funding

NatWest Treasury Markets

Tel: +44 7385 366760

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the information in the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

NatWest Markets Plc - RR3QWICWWIPCS8A4S074

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTDLLFLXXLXBBZ
Date   Source Headline
27th May 20261:56 pmRNSPublication of Final Terms
14th May 20266:41 pmRNSPublication of a Supplementary Prospectus
13th May 20267:00 amRNSNatWest Group plc notes rating actions by Fitch
13th May 20267:00 amRNSQ1 2026 Pillar 3
1st May 20265:21 pmRNSPublication of a Supplementary Prospectus
1st May 20267:00 amRNSNWM Plc Q1 Results 2026
25th Mar 20265:14 pmRNSFinal Terms
20th Mar 20264:58 pmRNSPublication of Final Terms
16th Mar 20265:54 pmRNSNWM Plc Registration Document and Base Prospectus
16th Mar 20265:43 pmRNSPublication of Final Terms
16th Mar 20265:29 pmRNSPublication of Final Terms
11th Mar 20265:46 pmRNSPublication of Final Terms
2nd Mar 20265:36 pmRNSPublication of Final Terms
13th Feb 20266:16 pmRNSPublication of Supplementary Prospectus
13th Feb 20267:00 amRNSNatWest Markets Plc Annual Report 2025
13th Feb 20267:00 amRNSNatWest Markets Plc Annual Results 2025
13th Jan 202612:17 pmRNSPublication of Final Terms
16th Dec 20251:03 pmRNSPublication of Final Terms
5th Dec 202512:44 pmRNSPublication of a Prospectus
12th Nov 20257:00 amRNSQ3 2025 Pillar 3
6th Nov 20255:30 pmRNSFinal Terms
24th Oct 20251:23 pmRNSPublication of Suppl.Prospcts
24th Oct 20257:00 amRNSNWM Plc Q3 Results 2025
8th Oct 202510:09 amRNSPublication of Final Terms
3rd Oct 202510:22 amRNSPublication of Final Terms
30th Sep 202510:59 amRNSPublication of Final Terms
3rd Sep 202512:42 pmRNSPublication of Final Terms
22nd Aug 20255:41 pmRNSAmendment RNS: Publication of Final Terms
20th Aug 20255:23 pmRNSPublication of Final Terms
20th Aug 20254:35 pmRNSPublication of Final Terms
12th Aug 20257:00 amRNSH1 2025 Pillar 3
25th Jul 20254:58 pmRNSPublication of Supplementary Prospectus
25th Jul 20257:01 amRNSNatWest Markets Plc Interim Results 2025
8th Jul 20253:03 pmRNSPublication of Final Terms
27th Jun 202512:50 pmRNSNatWest Group plc notes rating actions by Fitch
9th Jun 20252:46 pmRNSPublication of Final Terms
28th May 20255:00 pmRNSPublication of Pricing Supplement
13th May 20257:00 amRNSQ1 2025 Pillar 3
12th May 20252:50 pmRNSPublication of Final Terms
2nd May 20251:33 pmRNSPublication of Suppl.Prospcts
2nd May 20257:00 amRNSNatWest Markets Plc Q1 Results 2025
27th Mar 20256:25 pmRNSPublication of Suppl.Prospcts
25th Mar 20254:04 pmRNSNWM Plc Interim Chair
21st Mar 20253:41 pmRNSPublication of Supplementary Prospectus
19th Mar 202512:22 pmRNSPublication of Final Terms
17th Mar 20251:33 pmRNSNWM Plc Registration Document and Base Prospectus
14th Feb 20254:18 pmRNSPublication of Suppl.Prospcts
14th Feb 20258:00 amRNSNWM Plc 2024 Annual Report
14th Feb 20257:00 amRNSNWM Plc 2024 Annual Report
14th Feb 20257:00 amRNSNWM Plc 2024 Annual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.